Back to top of page

Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required)

- Name of the project: Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE

- Funding organization: NIH INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Project

- Grant type: Exploratory/Developmental Phased Innovation (R61/R33) grant

- Purpose: To improve health and quality-of-life for individuals with Down syndrome by supporting the development of clinical trials to treat critical and co-occurring health conditions

- Project duration: Up to five years

- R61 phase duration: Up to two years for preliminary/developmental/planning studies

- R33 phase duration: Up to three years for clinical trial support

- Required component: Measurable R61 milestones

Apply Now
Dollar sign symbol

Funding Amount

Clipboard symbol with a small checkmark bottom right

Eligible Applicants

Checkmark

Eligible Activities

Clock symbol

Deadline to Apply

Apply for Funding

88%

Approval rating across all Canadian funding programs

93%

Average time savings to our clients, compared to
businesses that apply for funding in-house
Woman on high chair reading a book in a small room with windows